
The Pharmacological Treadmill: How GLP-1 Agonists and Longevity Arbitrage are Rewiring the Fitness Economy
The fitness and nutrition sector is undergoing a radical structural realignment driven by GLP-1 agonists, FDA peptide enforcement, and the commerciali...
Read Full Story →





